Logo image of XTLB

XTL BIOPHARMACEUTICALS-ADR (XTLB) Stock Analyst Earnings Estimates

NASDAQ:XTLB - Nasdaq - US98386D3070 - ADR - Currency: USD

1.41  -0.1 (-6.62%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018
Revenue
YoY % growth
XTLB revenue by date.XTLB revenue by date.
EBITDA
YoY % growth
XTLB ebitda by date.XTLB ebitda by date.
-1.97M-2M
-1.52%		-1.71M
14.50%		-1.25M
26.90%		N/A
EBIT
YoY % growth
XTLB ebit by date.XTLB ebit by date.
-2.02M-2.01M
0.50%		-1.71M
14.93%		-1.25M
26.90%		-790K
36.80%
Operating Margin
XTLB operating margin by date.XTLB operating margin by date.
N/AN/AN/AN/AN/A
EPS
YoY % growth
XTLB eps by date.XTLB eps by date.
N/AN/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
XTLB Yearly EPS VS EstimatesXTLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
XTLB Yearly Revenue VS EstimatesXTLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A